DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
22 mars 2024 16h16 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS annonce l'octroi d'options d'achat d'actions
04 mars 2024 15h45 HE
|
DIAGNOS inc.
BROSSARD, Québec, 04 mars 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans le dépistage précoce de...
DIAGNOS Announces Grant of Stock Options
04 mars 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, March 04, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS souhaite la bienvenue à M. Michael Braeuel au sein de son conseil d'administration
29 févr. 2024 11h10 HE
|
DIAGNOS inc.
BROSSARD, Québec, 29 févr. 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), une pionnière de la détection précoce des...
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors
29 févr. 2024 11h10 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
With Extensive Two-Year Revenue Growth, ValueSelling Associates is Selected to Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies
28 févr. 2024 13h09 HE
|
ValueSelling Associates, Inc.
ValueSelling Associates has been selected to the Inc. 5000 Regionals Pacific list, showcasing the fastest-growing Pacific private companies.
DIAGNOS Announces Closing of First Tranche of Private Placement
27 févr. 2024 16h13 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 27, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
Diagnos Announces Variation in One Insider Ownership of Common Shares
23 févr. 2024 15h50 HE
|
DIAGNOS Inc.
BROSSARD, Québec, Feb. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that on...
DIAGNOS est reconnue comme l'une des meilleures sociétés de la Bourse de croissance TSX
21 févr. 2024 09h00 HE
|
DIAGNOS inc.
BROSSARD, Québec, 21 févr. 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), pionnière de la détection précoce des...
DIAGNOS recognized as a Top TSX Venture Exchange Company
21 févr. 2024 09h00 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Feb. 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...